Vanguard Group’s iSpecimen ISPC Stock Holding History
Bought
Maintained
Sold
Other funds holding ISPC
JF
TRCT
S
SS
Vanguard Group's ISPC Position: Q4 2025 in Review
Vanguard Group held its iSpecimen (ISPC) position steady in Q4 2025 at 735 shares worth $7.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4325.
Vanguard Group first reported a position in ISPC in Q4 2021 and has held it in 13 quarters since. The position peaked at $709K in Q4 2021. 9 funds tracked by Wall St. Rank hold ISPC as of Q4 2025.
- Vanguard Group held 735 shares of iSpecimen worth $7.65K as of Q4 2025.
- Vanguard Group left its iSpecimen share count unchanged in Q4 2025.
- iSpecimen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4325 holding.
- Vanguard Group first reported a position in iSpecimen in Q4 2021 and has held it in 13 quarters since.
- Vanguard Group's iSpecimen position peaked at $709K in Q4 2021.
- 9 funds tracked by Wall St. Rank held iSpecimen as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.